Jefferies Group LLC Bluebird Bio, Inc. Call Options Transaction History

Jefferies Group LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $180,400 - $220,900	-10,000 Closed	0 $0
Q1 2021 Sep 21, 2023	SELL	$16.59 - $33.89 $1.49 Million - $3.05 Million	-89,900 Reduced 89.99%	10,000 $195,000
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $1.49 Million - $3.05 Million	-89,900 Reduced 89.99%	10,000 $302,000
Q4 2020 Sep 21, 2023	BUY	$27.5 - $37.92 $2.75 Million - $3.79 Million	99,900 New	99,900 $2.8 Million
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $2,750 - $3,792	-100 Reduced 0.1%	99,900 $4.32 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $43.75 $3.27 Million - $4.16 Million	95,000 Added 1900.0%	100,000 $5.4 Million
Q4 2019 Feb 13, 2020	BUY	$46.96 - $61.67 $234,800 - $308,350	5,000 New	5,000 $439,000
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $915,258 - $1.21 Million	-10,300 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $1.03 Million - $1.31 Million	10,300 New	10,300 $1.62 Million

144

63.2M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $628M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.